Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ATXS | US
0.21
1.75%
Healthcare
Biotechnology
30/06/2024
30/08/2024
12.23
12.11
12.57
11.83
Astria Therapeutics Inc. a biopharmaceutical company focuses on the discovery development and commercialization of therapeutics for rare and niche allergic and immunological diseases in the United States. Its lead product candidate is STAR-0215 a monoclonal antibody inhibitor of plasma kallikrein which is in clinical development stage for the treatment of hereditary angioedema. The company was formerly known as Catabasis Pharmaceuticals Inc. and changed its name to Astria Therapeutics Inc. in September 2021. Astria Therapeutics Inc. was incorporated in 2008 and is based in Boston Massachusetts.
View LessStrength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Smallcap (300M - 2B USD)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
34.2%1 month
68.6%3 months
57.5%6 months
56.7%-
-
2.74
0.02
0.02
-7.57
-
-
-32.38M
690.08M
690.08M
-
-
-
-
-34.06
12.31
7.27
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.91
Range1M
3.42
Range3M
4.08
Rel. volume
2.28
Price X volume
8.66M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
AbCellera Biologics Inc | ABCL | Biotechnology | 2.56 | 754.34M | 1.19% | n/a | 6.49% |
Scholar Rock Holding Corporation | SRRK | Biotechnology | 9.3 | 744.30M | -0.21% | n/a | 0.00% |
Corbus Pharmaceuticals Holdings Inc | CRBP | Biotechnology | 61.18 | 736.85M | 5.46% | n/a | 11.79% |
ORIC Pharmaceuticals Inc | ORIC | Biotechnology | 10.37 | 731.53M | 1.67% | n/a | 0.92% |
Arbutus Biopharma Corporation | ABUS | Biotechnology | 3.87 | 730.59M | 1.04% | n/a | 6.09% |
iShares $ Corp Bond ETF USD Dist | LQDA | Biotechnology | 9.51 | 730.31M | -0.31% | n/a | 4.70% |
Applied Therapeutics Inc | APLT | Biotechnology | 6.34 | 728.12M | 4.28% | n/a | 0.30% |
Travere Therapeutics Inc. | TVTX | Biotechnology | 9.47 | 724.37M | 1.18% | n/a | 2662.08% |
Humacyte Inc | HUMA | Biotechnology | 6.05 | 722.07M | -1.63% | n/a | -63.37% |
Mereo BioPharma Group plc | MREO | Biotechnology | 4.69 | 721.57M | 2.40% | n/a | 7.83% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Malibu Boats Inc | MBUU | Recreational Vehicles | 36.37 | 743.39M | 4.66% | n/a | 0.00% |
Latham Group Inc. | SWIM | Building Products & Equipment | 6.25 | 722.36M | 0.32% | 56.82 | 77.00% |
Ennis Inc | EBF | Building Products & Equipment | 23.91 | 621.28M | 1.18% | 14.94 | 2.42% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.48 | 524.97M | 0.55% | n/a | 174.23% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 12.45 | 391.86M | -0.16% | 49.80 | 88.92% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 24.03 | 385.84M | 0.33% | n/a | 286.96% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.4 | 326.35M | 0.00% | 12.70 | 0.00% |
CPI Card Group Inc | PMTS | Building Products & Equipment | 28.64 | 316.93M | -0.52% | 18.84 | -621.78% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 18.53 | 314.66M | -0.70% | 36.33 | 26.79% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 15.53 | 251.70M | 1.70% | 9.96 | 15.44% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -7.57 | 0.97 | Cheaper |
Ent. to Revenue | - | 3,681.29 | - |
PE Ratio | - | 39.83 | - |
Price to Book | 2.74 | 14.54 | Cheaper |
Dividend Yield | - | 2.19 | - |
Std. Deviation (3M) | 57.47 | 76.13 | Lower Risk |
Debt to Equity | 0.02 | -2.05 | Expensive |
Debt to Assets | 0.02 | 0.25 | Cheaper |
Market Cap | 690.08M | 4.04B | Emerging |